Your browser doesn't support javascript.
loading
ISL1 predicts poor outcomes for patients with gastric cancer and drives tumor progression through binding to the ZEB1 promoter together with SETD7.
Guo, Ting; Wen, Xian-Zi; Li, Zi-Yu; Han, Hai-Bo; Zhang, Chen-Guang; Bai, Yan-Hua; Xing, Xiao-Fang; Cheng, Xiao-Jing; Du, Hong; Hu, Ying; Wang, Xiao-Hong; Jia, Yong-Ning; Nie, Meng-Lin; Xie, Meng; Li, Qing-Da; Ji, Jia-Fu.
Afiliación
  • Guo T; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Wen XZ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Li ZY; Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China.
  • Han HB; The Tissue Bank, Peking University Cancer Hospital & Institute, Beijing, China.
  • Zhang CG; Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Capital Medical University, Beijing, China.
  • Bai YH; Department of Pathology, Peking University Cancer Hospital & Institute, Beijing, China.
  • Xing XF; The Tissue Bank, Peking University Cancer Hospital & Institute, Beijing, China.
  • Cheng XJ; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Du H; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Hu Y; The Tissue Bank, Peking University Cancer Hospital & Institute, Beijing, China.
  • Wang XH; The Tissue Bank, Peking University Cancer Hospital & Institute, Beijing, China.
  • Jia YN; Department of Gastrointestinal Surgery, Peking University Cancer Hospital & Institute, Beijing, China.
  • Nie ML; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Xie M; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Li QD; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China.
  • Ji JF; Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Division of Gastrointestinal Cancer Translational Research Laboratory, Peking University Cancer Hospital & Institute, Beijing, China. jijiafu@hsc.pku.edu.cn.
Cell Death Dis ; 10(2): 33, 2019 01 15.
Article en En | MEDLINE | ID: mdl-30674889

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Factores de Transcripción / N-Metiltransferasa de Histona-Lisina / Proteínas con Homeodominio LIM / Homeobox 1 de Unión a la E-Box con Dedos de Zinc Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Dis Año: 2019 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Factores de Transcripción / N-Metiltransferasa de Histona-Lisina / Proteínas con Homeodominio LIM / Homeobox 1 de Unión a la E-Box con Dedos de Zinc Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cell Death Dis Año: 2019 Tipo del documento: Article